Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novantrone in AIDS-Related Kaposi's Sarcoma
NCT00002259Phase 2Completed
- Sponsor
- Lederle Laboratories
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mitoxantrone in Kaposi sarcoma (KS), sponsored by Lederle Laboratories. Primary endpoints: Toxicity and Efficacy. Status: completed.
02
Drugs
mitoxantrone
03
Conditions
Kaposi sarcoma (KS)
Beyond the preview
Go deeper on NCT00002259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002259.